| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 491.02M | 623.46M | 440.81M | 359.57M | 728.10M |
| Gross Profit | 45.41M | 31.30M | 36.62M | 27.27M | 41.59M |
| EBITDA | -80.71M | 120.27M | -23.12M | -31.48M | 48.22M |
| Net Income | -131.87M | 66.62M | 289.52M | -212.49M | -96.26M |
Balance Sheet | |||||
| Total Assets | 572.15M | 568.84M | 575.36M | 687.11M | 935.08M |
| Cash, Cash Equivalents and Short-Term Investments | 1.35M | 5.10M | 13.55M | 4.28M | 7.83M |
| Total Debt | 325.44M | 299.74M | 441.08M | 796.48M | 929.61M |
| Total Liabilities | 916.18M | 787.09M | 957.21M | 1.37B | 1.44B |
| Stockholders Equity | -344.03M | -218.25M | -375.92M | -675.04M | -494.19M |
Cash Flow | |||||
| Free Cash Flow | -38.98M | -192.38M | 87.80M | 13.14M | -285.45M |
| Operating Cash Flow | -36.95M | -114.66M | 88.39M | 13.28M | -283.86M |
| Investing Cash Flow | -623.00K | -76.51M | -589.00K | 19.64M | 383.12M |
| Financing Cash Flow | 33.70M | 182.97M | -78.30M | -36.13M | -112.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
88 Outperform | HK$3.30B | 8.02 | 12.93% | 3.74% | 22.72% | 41.32% | |
75 Outperform | HK$1.19B | 7.69 | 5.61% | 10.44% | -1.52% | 6.08% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | HK$330.00M | ― | 3.94% | 0.78% | 6.35% | -52.30% | |
56 Neutral | HK$1.01B | 5.21 | 4.38% | 5.38% | -11.88% | -61.92% | |
44 Neutral | HK$1.07B | 10.83 | -11.47% | ― | 13.86% | -83.41% | |
39 Underperform | HK$146.78M | -1.33 | ― | ― | -21.24% | -234.18% |